Showing results (1641-1650 of 1,724) with videos related to

Sort By:
Pageof 173
Cancer|April 7, 2021
Characterizing participants in the North Carolina Breast and Cervical Cancer Control Program: A retrospective review of 90,000 womenSarah D Tait, Yi Ren, Cushanta C Horton, et al.
Plos One|November 28, 2012
GSK3beta-mediated Drp1 phosphorylation induced elongated mitochondrial morphology against oxidative stressChia-Hua Chou, Ching-Chih Lin, Ming-Chang Yang, et al.
Cell Communication and Signaling : CCS|December 27, 2022
BMX, a specific HDAC8 inhibitor, with TMZ for advanced CRC therapy: a novel synergic effect to elicit p53-, β-catenin- and MGMT-dependent apoptotic cell deathHuey-Jiun Ko, Shean-Jaw Chiou, Cheng-Yu Tsai, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 8, 2022
FDA Approval Summary: Ivosidenib for the Treatment of Patients with Advanced Unresectable or Metastatic, Chemotherapy Refractory Cholangiocarcinoma with an IDH1 MutationSandra J Casak, Shan Pradhan, Lola A Fashoyin-Aje, et al.
Oncology Reports|September 30, 2010
Differential expression of hedgehog signaling components and Snail/E-cadherin in human brain tumorsChia-Hua Chou, Ann-Shung Lieu, Chia-Hung Wu, et al.
Molecular Cell|April 10, 2018
JMJD6 Licenses ERα-Dependent Enhancer and Coding Gene Activation by Modulating the Recruitment of the CARM1/MED12 Co-activator ComplexWei-Wei Gao, Rong-Quan Xiao, Wen-Juan Zhang, et al.
European Urology Oncology|December 12, 2024
Digital Pathology-based Artificial Intelligence Biomarker Validation in Metastatic Prostate CancerMark C Markowski, Yi Ren, Meghan Tierney, et al.
Journal of the National Cancer Institute|July 10, 2026
Combining pathology artificial intelligence and genomic biomarkers to refine long-term postprostatectomy outcome predictionMatthew R Cooperberg, Kevin Shee, Janet E Cowan, et al.
International Journal of Surgery (London, England)|November 26, 2025
Robotic hepatobiliary and pancreatic surgery using the chinese domestic robotic platforms: a multicenter retrospective cohort study on prospectively collected dataWei-Bo Chen, Wen-Bo Zou, Meng Zhang, et al.
The Oncologist|July 6, 2024
FDA approval summary: fam-trastuzumab deruxtecan-nxki for unresectable or metastatic non-small cell lung cancer with activating HER2 mutationsGautam U Mehta, Paz J Vellanki, Yi Ren, et al.
Pageof 173